Description:

Fulzos is a hormonal treatment for advanced or metastatic breast cancer in postmenopausal women. It contains fulvestrant, an estrogen receptor antagonist that degrades the estrogen receptor, preventing estrogen from stimulating cancer cell growth.

Fulzos is administered via intramuscular injection and is effective in patients who have developed resistance to previous hormonal therapies. It offers a unique mechanism of action in the hormone therapy landscape and provides clinical benefits in prolonging progression-free survival.

Write to Us

Share your experience with our medical product. Write a review!

Blog

14 Mar 2026

How Carica Papaya Leaf Extract Supports Platelet Recovery: Evidence, Uses & Best Practices

A healthy platelet count is essential for proper clotting, immune defense, and overall blood health. When platelet levels fall below normal-commonly referred to as low platelet count-the body becomes

Read More

05 Feb 2026

Food Habits That Increase Diabetes Risk - And How Fenugreek Can Help Manage Blood Sugar Naturally

Diet plays a crucial role in the development and management of type 2 diabetes.

Read More

20 Jan 2026

PCOS Symptoms and Management: Signs Most Women Overlook

Polycystic Ovary Syndrome (PCOS) is a common hormonal condition affecting millions of women worldwide. Early symptoms are often subtle and overlooked, which can delay diagnosis and treatment.

Read More

24 Dec 2025

Patch vs Pills: Why Transdermal Patches Are the Modern Choice for Pain & Wellness

(A Deep Dive into Pain Relief Patches, Wellness Patches & Modern Drug Delivery Technology)

Read More